CrushSCI.com
120.5Average days
128Median days
69Fastest days
178Longest days
1842025 publications

Paper Review Records

All Paper Review Records

21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

139 days

Population Pharmacokinetic Model for 6-chromanol SUL-238 Across Rats and Minipigs, a Novel Drug Designed to Protect and Restore Mitochondrial Function

Authors
Daniël H. Swart; Niels Westra; Marc A. Simon; Nadir Ulu; Rob H. Henning; Adrianus C. van der Graaf; Martin de Haan; Daan J. Touw; Guido Krenning; Paola Mian; Jasper StevensShow moreShow less
Affiliations
1. Pharmacometrics Expertise Center of Northern-Netherlands, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; 2. Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; 3. Sulfateq B.V., Groningen, The Netherlands; 4. Gen İlaç Ve Sağlık Ürünleri A.Ş., Çankaya, Turkey; 5. Madeha Management & Consultancy B.V., Nederhorst Den Berg, The Netherlands; 6. Department of Pharmaceutical Analysis, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The NetherlandsShow moreShow less
Source PDF DOI Publisher page
111 days

Predictive Performance of pyDarwin-Selected Versus Expert-Developed Paediatric Tobramycin Population Pharmacokinetic Models for Model-Informed Precision Dosing

Authors
Jinglei Wang; Kiera Harwood; Wenyu Yang; Alice Lei; Tony Lai; Keith Nieforth; Stephen Duffull; Mark Sale; Amanda Gwee; Xiao ZhuShow moreShow less
Affiliations
1. Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmaceutical Sciences, Fudan University, Shanghai, China; 2. Department of Paediatrics, The University of Melbourne, Melbourne, Australia; 3. Antimicrobial Group, Murdoch Children’s Research Institute, Melbourne, Australia; 4. Pharmacy Department, The Children’s Hospital at Westmead, Sydney, Australia; 5. School of Pharmacy, The University of Sydney, University of Sydney, Sydney, Australia; 6. Certara, Radnor, USA; 7. Clinical Pharmacology Unit, Department of General Medicine, and Department of Infectious Diseases, the Royal Children’s Hospital, Melbourne, AustraliaShow moreShow less
Source PDF DOI Publisher page
84 days

The Patient-Centric Formulation Compass: A Proposed Bottom-Up Framework to Translate Population Insights into Product Design

Authors
Domagoj Segregur; Pascal Somville; Jérôme Mantanus; Talia FlanaganShow moreShow less
Affiliations
1. CMC Development Sciences, UCB Pharma, Braine-L’Alleud, BelgiumShow moreShow less
Source PDF DOI Publisher page
103 days

Liquid Chromatography/tandem Mass Spectrometry-based Target Engagement of Lysine-specific Demethylase 1 Inhibitor TAK-418 Through Detecting Covalent Adducts in the Brain

Authors
Kota Matsumiya; Shinji Iwasaki; Satoru Matsuda; Yohei Kosugi; Hisao Shimizu; Masaaki Kakehi; Rina Baba; Nobuyuki Amano; Atsushi Nakatani; Haruhide Kimura; Hideki HirabayashiShow moreShow less
Affiliations
1. Drug Metabolism and Pharmacokinetics Research Laboratories, Takeda Pharmaceutical Company Limited, Fujisawa, Japan; 2. Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, JapanShow moreShow less
Source PDF DOI Publisher page
121 days

Physiologically based Biopharmaceutics Modeling (PBBM) Reveals a Low Dissolution-related Bioequivalence Risk for Immediate-Release Amlodipine Tablets

Authors
Porfirio de la Cruz Cruz; Larissa Lopes Rodrigues Gomide; Gabriela Moraes do Nascimento; José Trinidad Pérez Urizar; Alberto Martínez Muñoz; Ángel Antonio Vértiz Hernández; Amaury de Jesús Pozos Guillén; Héctor Eduardo Flores Reyes; Ricardo Zamora Ramírez; Luis Manuel Romero Cruz; Marcelino García Sánchez; Mauricio A. García; Michele Georges Issa; Marcelo Dutra DuqueShow moreShow less
Affiliations
1. Doctorado Institucional en Ingeniería y Ciencia de Materiales (DICIM) de la Universidad Autónoma de San Luis Potosí (UASLP), San Luis Potosí, México; 2. Department of Pharmaceutical Sciences, Institute of Environmental, Chemical, and Pharmaceutical Sciences, Universidade Federal de São Paulo (UNIFESP), Diadema, Brazil; 3. Facultad de Ciencias Químicas de la Universidad Autónoma de San Luis Potosí, San Luis Potosí, México; 4. FS SCIENTIA PHARMA S.A. de C.V (Authorized Third Party), San Luis Potosí, México; 5. Coordinación Académica Región Altiplano, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México; 6. Facultad de Estomatología, Laboratorio de Ciencias Básicas, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México; 7. Ultra Laboratorios S.A. de C.V., Investigación y Desarrollo. Guadalajara, Jalisco, México; 8. Departamento de Farmacia, Escuela de Química y Farmacia, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile; 9. Department of Pharmacy, Faculty of Pharmaceutical Sciences, Universidade de São Paulo (USP), São Paulo, BrazilShow moreShow less
Source PDF DOI Publisher page
128 days

Nanocarrier-Enabled Delivery of Glucosinolates for Skin Cancer Prevention and Therapy

Authors
Chandrika Chaturvedi; Carman Giacomantonio; H. P. Vasantha RupasingheShow moreShow less
Affiliations
1. Department of Plant, Food, and Environmental Sciences, Faculty of Agriculture, Dalhousie University, Truro, Canada; 2. Department of Surgery, Faculty of Medicine, Dalhousie University, Halifax, Canada; 3. Department of Pathology, Faculty of Medicine, Dalhousie University, Halifax, CanadaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does AAPS Journal take to review a manuscript?

As of 2026-11-19, CrushSCI has 21 complete review records for AAPS Journal. The fastest paper went from submission to acceptance in 69 days (Four decades of History & Evolution of Clinical Pharmacology at US Food and Drug Administration (FDA)– Part I: Product Quality, received 2026-06-03, accepted 2026-08-11); the slowest took 178 days. The average is 120.5 days and the median is 128 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.